Ignite Creation Date:
2024-05-05 @ 11:21 AM
Last Modification Date:
2024-10-26 @ 9:04 AM
Study NCT ID:
NCT00003992
Status:
COMPLETED
Last Update Posted:
2013-06-03
First Post:
1999-11-01
Brief Title:
Chemotherapy Plus Monoclonal Antibody Therapy in Treating Women With Stage II or Stage IIIA Breast Cancer That Overexpresses HER2
Sponsor:
National Cancer Institute NCI
Organization:
National Cancer Institute NCI